Indomethacin

SKU: orb1310593

Description

Indomethacin

Research Area

Cell Biology, Immunology & Inflammation, Metabolism Research, Neuroscience, Pharmacology & Drug Discovery

Key Properties

• CAS Number: 53-86-1
• MW: 357.788
• Purity: 99.84% (May vary between batches)
• Formula: C₁₉H₁₆ClNO₄
• SMILES: COC1=CC=C2N(C(=O)C3=CC=C(Cl)C=C3)C(C)=C(CC(O)=O)C2=C1
• Target: Phospholipase,COX,PDE,Autophagy
• Solubility: Ethanol:17.9 mg/mL (50.03 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.58 mg/mL (10.01 mM);DMSO:104 mg/mL (290.67 mM)

Bioactivity

• Target IC50:
  COX-1:0.28 μM|COX-2:14 μM
• In Vivo:
  METHODS: To test the antitumor activity in vivo, Indomethacin (1 mg/kg) was administered by gavage to CDF1 mice bearing Colon 26 xenografts twice daily for 7-21 days. RESULTS: Mean tumor weight was significantly lower in both the long-term and short-term Indomethacin administration groups, serum immunosuppressive acidic protein levels were significantly lower, serum IL-6 levels were also significantly lower, and prostaglandin E2 levels in tumor tissues were significantly lower than those in the control group.
  Read more...
• In Vitro:
  METHODS: Human gastric cancer cells AGS were treated with Indomethacin (100-500 µM) for 24 h, and the expression levels of target proteins were detected by Western Blot. RESULTS: Indomethacin increased LC3-II protein levels in AGS cells, which may be a result of induction of autophagy or inhibition of lysosome-dependent autophagic degradation. METHODS: Human tumor cells HT29 and A431 were treated with Indomethacin (1-10 µM) and EGF (25 ng/mL) for 24-48 h. Cell migration was detected by wound-healing assay. RESULTS: Indomethacin inhibited HT29 cell migration. After treating A431 cells with EGF only, the wound closed within 24 h, but the wound remained open after 24 h of treatment with Indomethacin.
  Read more...

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

COX-2, COX-1, COX, Cyclooxygenase, anticancer, anti-infective, Autophagy, Inhibitor, PDE2, inhibit, Indocin, inflammation, Indometacin, Indometacine, Indomethacin, Indomethacine, PLA2

Compound Identifiers

PubChem CID

3715